ArticleFuture science OA2022

Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study.

Dan Bates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.